160 related articles for article (PubMed ID: 30034638)
1. Correction: Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer.
Terlizzi M; Colarusso C; De Rosa I; De Rosa N; Somma P; Curcio C; Sanduzzi A; Micheli P; Molino A; Saccomanno A; Salvi R; Aquino RP; Pinto A; Sorrentino R
Oncotarget; 2018 Jun; 9(50):29537. PubMed ID: 30034638
[TBL] [Abstract][Full Text] [Related]
2. Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer.
Terlizzi M; Colarusso C; De Rosa I; De Rosa N; Somma P; Curcio C; Sanduzzi A; Micheli P; Molino A; Saccomanno A; Salvi R; Aquino RP; Pinto A; Sorrentino R
Oncotarget; 2018 Apr; 9(27):19356-19367. PubMed ID: 29721208
[TBL] [Abstract][Full Text] [Related]
3. Correction: Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer.
Zhang S; Che D; Yang F; Chi C; Meng H; Shen J; Qi L; Liu F; Lv L; Li Y; Meng Q; Liu J; Shang L; Yu Y
Oncotarget; 2020 Dec; 11(52):4845-4846. PubMed ID: 33447352
[TBL] [Abstract][Full Text] [Related]
4. Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability.
Munari E; Zamboni G; Marconi M; Sommaggio M; Brunelli M; Martignoni G; Netto GJ; Moretta F; Mingari MC; Salgarello M; Terzi A; Picece V; Pomari C; Lunardi G; Cavazza A; Rossi G; Moretta L; Bogina G
Oncotarget; 2018 Dec; 9(97):37077. PubMed ID: 30651938
[TBL] [Abstract][Full Text] [Related]
5. Correction: Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis.
Chi S; Shen L; Hua T; Liu S; Zhuang G; Wang X; Zhou X; Wang G; Wang H
Oncotarget; 2017 Nov; 8(59):100957. PubMed ID: 29243743
[TBL] [Abstract][Full Text] [Related]
6. Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.
Chretien AS; Fauriat C; Orlanducci F; Rey J; Borg GB; Gautherot E; Granjeaud S; Demerle C; Hamel JF; Cerwenka A; von Strandmann EP; Ifrah N; Lacombe C; Cornillet-Lefebvre P; Delaunay J; Toubert A; Arnoulet C; Vey N; Olive D
Oncotarget; 2019 Sep; 10(52):5493. PubMed ID: 31534634
[TBL] [Abstract][Full Text] [Related]
7. Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer.
Xu N; Fang W; Mu L; Tang Y; Gao L; Ren S; Cao D; Zhou L; Zhang A; Liu D; Zhou C; Wong KK; Yu L; Zhang L; Chen L
Oncotarget; 2018 Oct; 9(81):35284. PubMed ID: 30443296
[TBL] [Abstract][Full Text] [Related]
8. Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients.
Kageyama SI; Nihei K; Karasawa K; Sawada T; Koizumi F; Yamaguchi S; Kato S; Hojo H; Motegi A; Tsuchihara K; Akimoto T
Oncotarget; 2018 May; 9(34):23844. PubMed ID: 29809194
[TBL] [Abstract][Full Text] [Related]
9. Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; Vecchia C; Sozzi G; Pastorino U
Oncotarget; 2019 Oct; 10(57):6043. PubMed ID: 31666934
[TBL] [Abstract][Full Text] [Related]
10. Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed.
Zhang N; Kong L; Shi F; Jing W; Wang H; Yang M; Yu J; Zhu H
Oncotarget; 2017 Dec; 8(66):110732. PubMed ID: 29300397
[TBL] [Abstract][Full Text] [Related]
11. Correction: Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis.
Pei D; Li Y; Liu X; Yan S; Guo X; Xu X; Guo X
Oncotarget; 2018 Apr; 9(30):21628. PubMed ID: 29765564
[TBL] [Abstract][Full Text] [Related]
12. Correction: A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01).
Kim HR; Jang JS; Sun JM; Ahn MJ; Kim DW; Jung I; Lee KH; Kim JH; Lee DH; Kim SW; Cho BC
Oncotarget; 2017 Aug; 8(33):55766. PubMed ID: 28903459
[TBL] [Abstract][Full Text] [Related]
13. Correction: Artocarpin, an isoprenyl flavonoid, induces p53-dependent or independent apoptosis via ROS-mediated MAPKs and Akt activation in non-small cell lung cancer cells.
Tsai MH; Liu JF; Chiang YC; Hu SC; Hsu LF; Lin YC; Lin ZC; Lee HC; Chen MC; Huang CL; Lee CW
Oncotarget; 2019 May; 10(36):3430. PubMed ID: 31448047
[TBL] [Abstract][Full Text] [Related]
14. Correction: Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma.
Boulos S; Park MC; Zeibak M; Foo SY; Jeon YK; Kim YT; Motzik A; Tshori S; Hamburger T; Kim S; Nechushtan H; Razin E
Oncotarget; 2018 Nov; 9(90):36250. PubMed ID: 30546840
[TBL] [Abstract][Full Text] [Related]
15. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
16. Correction: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy.
Hsu TI; Chen YJ; Hung CY; Wang YC; Lin SJ; Su WC; Lai MD; Kim SY; Wang Q; Qian K; Goto M; Zhao Y; Kashiwada Y; Lee KH; Chang WC; Hung JJ
Oncotarget; 2019 Nov; 10(60):6536-6537. PubMed ID: 31741716
[TBL] [Abstract][Full Text] [Related]
17. Correction: B7-H4 as an independent prognostic indicator of cancer patients: a meta-analysis.
Meng Z; Wang F; Zhang Y; Li S; Wu H
Oncotarget; 2018 Feb; 9(16):13100. PubMed ID: 29569655
[TBL] [Abstract][Full Text] [Related]
18. Correction: Quinacrine inhibits GSTA1 activity and induces apoptosis through G
Kumar M; Martin A; Nirgude S; Chaudhary B; Mondal S; Sarkar A
Oncotarget; 2020 Nov; 11(46):4364-4365. PubMed ID: 33245730
[TBL] [Abstract][Full Text] [Related]
19. Correction: COTI-2, a novel small molecule that is active against multiple human cancer cell lines
Salim KY; Vareki SM; Danter WR; San-Marina S; Koropatnick J
Oncotarget; 2017 Sep; 8(36):60724. PubMed ID: 29062467
[TBL] [Abstract][Full Text] [Related]
20. Correction: An updated meta-analysis of the prognostic value of decreased E-cadherin expression in ovarian cancer.
Yu L; Hua X; Yang Y; Li K; Zhang Q; Yu L
Oncotarget; 2018 Apr; 9(28):20220. PubMed ID: 29733082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
